OBJECTIVES-To report phenotypic characteristics of 32 age-validated supercentenarians.
DESIGN-Case series.
SETTING-U.S.-based recruitment effort.
PARTICIPANTS-Thirty-two supercentenarians.MEASUREMENTS-Multiple forms of proof were used to validate age claims. Sociodemographic, activities of daily living, and medical history data were collected. RESULTS-Age range was 110 to 119. Fifty-nine percent had Barthel Index scores in the partially to totally dependent range, whereas 41% required minimal assistance or were independent. Few subjects had a history of clinically evident vascular-related diseases, including myocardial infarction (n = 2, 6%) and stroke (n = 4, 13%). Twenty-two percent (n = 7) were taking medications for hypertension. Twenty-five percent (n = 8) had a history of cancer (all cured). Diabetes mellitus (n = 1, 3%) and Parkinson's disease (n = 1, 3%) were rare. Osteoporosis (n = 14, 44%) and cataract history (n = 28, 88%) were common.CONCLUSION-Data collected thus far suggest that supercentenarians markedly delay and even escape clinical expression of vascular disease toward the end of their exceptionally long lives. A surprisingly substantial proportion of these individuals were still functionally independent or required minimal assistance.
Keywordssupercentenarian; centenarian; longevity Address correspondence to Thomas T. Perls, MD, MPH, New England Centenarian Study, Boston University Medical Center, 88 East Newton St., Robinson 2400, Boston, MA 02118. thperls@bu.edu. Author Contributions: Dr. Perls played key roles in all aspects of the preparation of this manuscript. Emily Schoenhofen played key roles in study concept and design, subject acquisition and data analysis. Dr. Wyszynski played a key role in data analysis and interpretation. Stacy Andersen played key roles in subject recruitment and enrollment and data collection, analysis, and interpretation. Robert Young played key roles in subject recruitment, ascertainment of demographic data, and age validation. JaeMi Pennington played key roles in subject recruitment and enrollment and data collection. Dr. Terry played key roles in study concept and design, data interpretation, and preparation of the manuscript. The remarkable growth in the number of centenarians (aged ≥ 100) has garnered significant attention over the past 20 or so years. Consequently, a number of centenarian studies have emerged, ranging in emphasis from demographic to genetic. Recently, an even more extreme group, supercentenarians, or people aged 110 and older, has begun to yield sufficient numbers to warrant descriptive studies.
NIH Public AccessGreat effort and diligence is required to locate living supercentenarians and validate their age claims. Claims of ages beyond that of the oldest well-accepted age of 122 years (Madame Jeanne Calment) regularly surface in the media, but these are invariably unsubstantiated. [1][2][3] The U.S. census listed 1,400 supercentenarians in 2000 (about 1 per 200,000), 4 but an e-mail based effort facilitated by the Gerontology Rese...